
NHS First in Europe to Offer New Subcutaneous Cancer Jab
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a subcutaneous injectable version of the cancer drug nivolumab (Opdivo, Bristol Myers Squibb). NHS England said it would be the first health service in Europe to offer this …